Ed Roschak

Ed Roschak began their career in 2000 as the Senior Vice President of Research and Development at Broncus Technologies. In 2010, they took on the roles of President, CEO, Director and Chief Operating Officer at Ellipse Technologies, Inc., which was acquired by NuVasive in 2016. In the same year, they became the CEO of NuVasive Specialized Orthopedics. Ed then became the Chairman of ApiFix, which was acquired by Orthopediatrics in 2017. In the same year, they became the President, CEO, and Director of Vascular Dynamics. Finally, in 2019 they became a Director at Perfuze.

Ed Roschak completed their MBA at the University of Oregon from 1997 to 1999. Ed then went on to obtain a BSME from UC Santa Barbara from 1985 to 1989.